Brief: Percheron Therapeutics Submits Non-Binding Proposal To In-License New Clinic-Ready Drug Development Program
Feb 24 (Reuters) - Percheron Therapeutics Ltd PER.AX :
* SUBMITS NON-BINDING PROPOSAL TO IN-LICENSE NEW
CLINIC-READY DRUG
DEVELOPMENT PROGRAM
Further company coverage: PER.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Percheron Therapeutics
See all newsBrief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Brief: Percheron Therapeutics Receives Firm Commitments For A$2.3 Million Institutional Placement
Brief: Percheron Therapeutics Appoints Ambrosini as Interim Board Member During CEO Transition Period
Brief: Percheron Therapeutics Says Vanderbilt Health To Conduct Clinical Trial Of Hmbd-002 In Acute Myeloid Leukaemia
Brief: Percheron Therapeutics Says James Garner To Step Down As CEO And Managing Director